Related Experiment Videos
White cell-associated procoagulant activity induced by ABO incompatibility
R D Davenport1, T J Polak, S L Kunkel
1Department of Pathology, University of Michigan, Ann Arbor.
Transfusion
|November 1, 1994
Summary
White blood cells generate procoagulant activity (PCA) during ABO red blood cell (RBC) incompatibility, potentially causing disseminated intravascular coagulation in transfusion reactions. This PCA involves tissue factor and CD11b-dependent mechanisms.
Area of Science:
- Hematology
- Immunology
- Transfusion Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a known complication of acute hemolytic transfusion reactions (aHTRs).
- Immune hemolysis, particularly ABO incompatible red blood cell (RBC) reactions, can activate coagulation.
- Peripheral blood white cells, especially monocytes, can express procoagulant activity (PCA) under inflammatory conditions.
Purpose of the Study:
- To investigate the expression of PCA by peripheral blood white cells in ABO RBC incompatibility.
- To elucidate the mechanisms of coagulation activation during immune hemolysis.
Main Methods:
- Incubation of group O whole blood with incompatible (group A) or compatible (group O) RBCs.
- Separation, washing, and lysis of white cells for PCA assay using a clotting time method.
- Investigation of coagulation activation pathways using factor-deficient plasmas, anti-tissue factor antibodies, and anti-CD11b antibodies.
Main Results:
- Significant white cell-associated PCA was observed in response to incompatible RBCs, but not compatible RBCs.
- PCA generation required complement and protein synthesis, and was dependent on tissue factor and a CD11b-mediated mechanism.
- PCA was reduced by factor VII-deficient plasma and factor X-deficient plasma, implicating the extrinsic pathway of coagulation.
Conclusions:
- White cell-associated PCA is generated during ABO RBC incompatibility.
- This PCA may contribute to DIC in acute hemolytic transfusion reactions.
- Mechanisms involve tissue factor expression and CD11b-dependent activation of factor X.